Search alternatives:
ejection » detection (Expand Search), selection (Expand Search)
Showing 21 - 39 results of 39 for search 'presented left ventricular ejection function*', query time: 0.12s Refine Results
  1. 21

    Case of Dengue Myocarditis Mimicking as Acute Myocardial Infarction: A Diagnostic Dilemma by Priya Baluni, Shubhangi A Kanitkar, Prasad Chandrakant Bagare, Vanshaj Sharma

    Published 2025-05-01
    “…A 2D echocardiogram revealed mild left atrial dilation, preserved systolic function {Left Ventricular Ejection Fraction (LVEF) 55-60%} and paradoxical interventricular septal motion. …”
    Get full text
    Article
  2. 22

    When viral myocarditis meets thrombosis tendency: deep analysis of a complex case report by Qian Ding, Yun Zhang, Dongbei Li, Wenhua Liu, Jing Feng, Shuang Li, Wei Chen, Mu Guo

    Published 2025-08-01
    “…Following treatment, inflammatory markers and coagulation function improved, cardiac function recovered (LVEF increased to 53%), and the thrombus resolved. …”
    Get full text
    Article
  3. 23

    Echocardiographic diagnosis of interarterial AAOCA in children: a framework integrating anatomical landmarks and systolic dysfunction for risk assessment by Rui Hu, Xuming Mo, Shanliang Zhu, Jun Chen, Ying Tang, Yumei Xu

    Published 2025-07-01
    “…Postoperatively, 10/11 cases achieved normal cardiac function. Conclusions Echocardiography provides a clinically actionable protocol for preoperative AAOCA diagnosis by integrating anatomical markers (Acute deviation, parallel course) and functional metrics (LVEF, wall motion). …”
    Get full text
    Article
  4. 24

    A Coupled Model of the Cardiovascular and Immune Systems to Analyze the Effects of COVID-19 Infection by Camila Ribeiro Passos, Alexandre Altamir Moreira, Ruy Freitas Reis, Rodrigo Weber dos Santos, Marcelo Lobosco, Bernardo Martins Rocha

    Published 2025-03-01
    “…The coupled model accurately replicated the evolution of cardiac function in survivors and non-survivors of COVID-19. …”
    Get full text
    Article
  5. 25

    Сlinical and hemodynamic characteristics and coronary blood flow in patients with chronic coronary artery disease and type 2 diabetes by B. U. Mardanov, M. A. Kokozheva, F. B. Shukurov, B. A. Rudenko, M. N. Mamedov

    Published 2022-01-01
    “…Among group I patients, electrocardiographic signs of left ventricular hypertrophy, conduction abnormalities, accompanied by a decrease in the left ventricular ejection fraction, impaired diastolic function, and high mean pulmonary artery pressure were significantly more often detected. …”
    Get full text
    Article
  6. 26

    ANTITHROMBOTIC THERAPY IN PREVENTION OF CARDIOVASCULAR EVENTS (DEATH, ACUTE MYOCARDIAL INFARCTION, STROKE) IN PATIENTS WITH CHRONIC HEART FAILURE by N.D. Gerasimenko, M.S. Rasin

    Published 2017-12-01
    “…It has been specified, which anticoagulants or antiplatelet agents have advantages taking into account the features of the functioning of organs and systems in patients with heart failure. …”
    Get full text
    Article
  7. 27

    Contrast-induced nephropathy in patients with acute coronary syndrome with ST-segment elevation: risk factors and prognosis by O. V. Arsenicheva, N. N. Shchapovа

    Published 2020-01-01
    “…Among patients with СIN, persons aged over 75 years (60 %), with diabetes mellitus (45 %), chronic kidney disease (75 %), postinfarction cardiosclerosis (50 %), chronic heart failure of functional class III–IV (80 %), developed acute heart failure T. …”
    Get full text
    Article
  8. 28

    ECMO‐Assisted Da Vinci Robotic Surgery for Pheochromocytoma‐Induced Acute Catecholamine Cardiomyopathy: A Case Report by Qi Wang, Jiayan Xin, Xiaoqiong Cui, Liya Hu, Meng Ning, Wenqing Gao, Yingwu Liu

    Published 2025-08-01
    “…The patient was able to resume her daily activities without any residual functional impairment. This case underscores the efficacy of the synergistic application of ECMO with robotic surgery in the management of pheochromocytoma‐induced ACIC. …”
    Get full text
    Article
  9. 29

    Characterization of cardiac sarcoidosis in Iranian patients using cardiac magnetic resonance and positron emission tomography imaging techniques by Simin Almasi, Amir Azimi, Kiyan Heshmat-Ghahdarijani, Amir Ghaffari Jolfayi, Mahsa Ghorbani, Shahla Meshgi, Maedeh Dastmardi, Ghazaleh SalehAbadi, Ali Mohammadzadeh

    Published 2025-07-01
    “…All patients underwent CMR to evaluate myocardial function, edema, scarring, and strain. 28 patients also underwent FDG-PET/CT to assess active myocardial inflammation. …”
    Get full text
    Article
  10. 30

    Non-compaction and dilated cardiomyopathy: genotypic, phenotypic and prognostic differences by T. G. Vaykhanskaya, L. N. Sivitskaya, O. D. Levdansky, T. V. Kurushko, N. G. Danilenko

    Published 2022-11-01
    “…To assess clinical outcomes, the NCM group was divided into 2 subtypes according to baseline LV systolic function (NCM/DCM phenotype — 50 individuals with LVEF ≤49%; and isolated NCM — 24 patients with LVEF ≥50%). …”
    Get full text
    Article
  11. 31

    Cardiac MRI of differing ischemia and reperfusion times in a myocardial infarction pig model by David Boll, Simon Reiss, Heidi R. Cristina Schmitz, Christian Weber, Julien Thielmann, Felix Spreter, Kian Tadjalli Mehr, Diana Chiang, Markus Jäckel, Lukas Heger, Jonathan Rilinger, Dirk Westermann, Constantin von zur Mühlen, Timo Heidt, Michael Bock, Alexander Maier

    Published 2025-07-01
    “…CMR was performed at a clinical 3 T system including functional imaging, T1 and T2 mapping and late gadolinium enhancement (LGE) 2–5 h or three days post-reperfusion. …”
    Get full text
    Article
  12. 32

    Role of the individual metabolic syndrome components and heart remodelling progression in women by E. M. Khurs, A. N. Dmitriev, A. V. Poddubnaya, E. M. Futerman

    Published 1970-01-01
    “…To analyze the dynamics of heart structure, geometry, and function in women, in accordance with present components of metabolic syndrome (MS). …”
    Get full text
    Article
  13. 33

    New possibilities of nephroprotection in patients with chronic heart failure in combination with chronic kidney disease and diabetes mellitus 2 or without it by E. V. Kovalenko, L. I. Markova, O. L. Belaya

    Published 2022-10-01
    “…Impaired kidney function has a negative impact on the course of heart failure in both patients with and without diabetes mellitus. …”
    Get full text
    Article
  14. 34

    Prevalence and Factors Associated with Excess Weight in Patients with Heart Failure in Cali, Colombia by Jhonatan Betancourt-Peña, Julieth Paola Suárez-Hernández, Guillermo Perlaza-Peláez, William Eduardo Escobar-Rodríguez, Adriana Orejuela-Upegui, Mauricio Hernández-Carrillo

    Published 2025-08-01
    “…The study included sociodemographic and clinical variables, functional aerobic capacity measured by the 6-minute walk test, quality of life assessed using the Minnesota Living with Heart Failure Questionnaire (MLFHQ), and depression evaluated by the Patient Health Questionnaire-9 (PHQ-9). …”
    Get full text
    Article
  15. 35

    Possibilities of hyperuricemia correction in acute decompensation of heart failure by Laura H. Sarieva, Svetlana N. Nasonova, Marina D. Muksinova, Igor V. Zhirov, Sergey N. Tereshchenko

    Published 2025-01-01
    “…The results of standard therapy of HF with diuretic therapy in combination with xanthine oxidase inhibitor – allopurinol in the starting dose of 50 mg in 36 patients with ADHF of functional class II–IV, hyperuricemia, reduced renal filtration function calculated by the CKD-EPI formula are presented. …”
    Get full text
    Article
  16. 36

    Allopurinol in the complex therapy of acute decompensation of heart failure by Laura H. Sarieva, Marina D. Muksinova, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko

    Published 2025-01-01
    “…Materials and methods. We present the results of a 6-month follow-up for 72 patients with ADHF, hyperuricemia, and reduced filtration function of the kidneys, calculated using the CKD-EPI formula, divided equally into two groups: group 1 received standard of care for HF combined with a xanthine oxidase inhibitor – allopurinol, and group 2 received standard of care only. …”
    Get full text
    Article
  17. 37

    Severity of obstructive sleep apnea and its impact on coronary artery disease outcomes: A cross-sectional study in Egypt by Hossam Eldin M. Mahmoud, Ahmed Hussein, Esraa A. Taha, Eptehal M. Dongol, Ahmed G. Bakry

    Published 2025-05-01
    “…Conclusion: OSA is prevalent in CAD patients and correlates with worsened cardiac function and increased CAD severity. STOP-BANG score is a useful screening tool. …”
    Get full text
    Article
  18. 38
  19. 39

    Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction by Marta Wleklik, Christopher S. Lee, Łukasz Lewandowski, Michał Czapla, Maria Jędrzejczyk, Heba Aldossary, Izabella Uchmanowicz

    Published 2025-06-01
    “…Frailty was assessed using Fried phenotype criteria. Cognitive function, depression and nutritional status were evaluated using validated instruments [Mini‐Mental State Examination (MMSE), Patient Health Questionnaire‐9 (PHQ‐9) and Mini Nutritional Assessment (MNA)]. …”
    Get full text
    Article